NewAmsterdam Pharma (NAMS) Goodwill & Intangibles (2022 - 2025)
Historic Goodwill & Intangibles for NewAmsterdam Pharma (NAMS) over the last 4 years, with Q3 2025 value amounting to $439000.0.
- NewAmsterdam Pharma's Goodwill & Intangibles fell 2596.96% to $439000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $439000.0, marking a year-over-year decrease of 2596.96%. This contributed to the annual value of $534000.0 for FY2024, which is 21411.76% up from last year.
- Per NewAmsterdam Pharma's latest filing, its Goodwill & Intangibles stood at $439000.0 for Q3 2025, which was down 2596.96% from $470000.0 recorded in Q2 2025.
- In the past 5 years, NewAmsterdam Pharma's Goodwill & Intangibles registered a high of $84.8 million during Q4 2022, and its lowest value of $88887.8 during Q2 2023.
- Over the past 4 years, NewAmsterdam Pharma's median Goodwill & Intangibles value was $494000.0 (recorded in 2024), while the average stood at $8.9 million.
- In the last 5 years, NewAmsterdam Pharma's Goodwill & Intangibles plummeted by 9979.96% in 2023 and then surged by 50975.75% in 2024.
- Over the past 4 years, NewAmsterdam Pharma's Goodwill & Intangibles (Quarter) stood at $84.8 million in 2022, then crashed by 99.8% to $170000.0 in 2023, then soared by 214.12% to $534000.0 in 2024, then fell by 17.79% to $439000.0 in 2025.
- Its last three reported values are $439000.0 in Q3 2025, $470000.0 for Q2 2025, and $502000.0 during Q1 2025.